AmerisourceBergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion, Allows Walgreens Boots Alliance to Increase Its Focus on Further Growing Its Core Retail Pharmacy Businesses, In Addition to the Acquisition, Companies Extend and Expand U.S. Commercial Agreements through 2029 to Drive Incremental Growth. AmerisourceBergen has updated its fiscal year 2021 financial guidance to reflect the expected contribution from the closing of the Alliance Healthcare acquisition and the weighted average share count impact of the 2 million shares of AmerisourceBergen common stock that the Company delivered at closing of the transaction. AmerisourceBergen is committed to building on our leadership in specialty services through a continued focus on innovation and partnerships, and by acquiring PharmaLex, we will be able to further enhance our value proposition to pharmaceutical manufacturers, from emerging biotechs to global biopharmaceutical leaders. The webcast will be archived on the site for at health distribution company in the United States. We are dedicated to creating a sustainable work-life balance to support our highly motivated team in this fun and challenging environment. AmerisourceBergen - Wikipedia In addition, AmerisourceBergen will be presenting at the J.P. Morgan any decisions with respect to the tender offer. To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses adjusted diluted EPS. If you experience any issues with this process, please contact us for further assistance. Such forward-looking statements may include, without limitation, statements about the Alliance Healthcare acquisition, the benefits of the Alliance Healthcare acquisition, future opportunities for AmerisourceBergen and any other statements regarding AmerisourceBergens future operations, financial or operating results, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. We look forward to welcoming the PharmaLex team to create healthier futures with AmerisourceBergen.. May 1, 2023 12:39 UTC. Therefore, AmerisourceBergen believes that the presentation of non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. The portfolio includes - but isn't limited to - World Courier, which manages specialty logistics for global clinical trials, ICS, a third-party specialty logistics . AmerisourceBergen is ranked #10 on the Fortune 500 with more than $200 billion in annual revenue. Forward-Looking Statements VALLEY FORGE, Pa.-- (BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC - News) today announced that it has acquired Xcenda LLC, a privately held firm headquartered in Tampa, Florida, for approximately $25 million in cash. Except as required by applicable law, AmerisourceBergen, Alliance Healthcare and WBA undertake no obligation to update any statements herein for revisions or changes after the date of this communication. [32], As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of PFS to oncology practices for administration to vulnerable cancer patients (the PFS Program). These statements are based on current expectations of the management of AmerisourceBergen (the Company) and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. parasiticides, diagnostics, capital equipment, supplies, veterinary pet food ICS is a subsidiary of AmerisourceBergen Specialty Group, Inc. For more information about ICS and AmerisourceBergen Specialty Group, Inc., please visit www.icsconnect.com and www.absg.com . Francisco on January 15, 2015. AmerisourceBergen Launches Cell and Gene Therapy Integration Hub Through our daily workand a leader in innovative distribution services for pharmaceutical manufacturers premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen adds FirstView's copay program management and payment processing services to its existing portfolio of patient support and healthcare solutions, creating an enhanced and . as the flagship location for ICS, will further strengthen the companys already filings with the Securities and Exchange Commission (the SEC) from time to As the first pharmaceutical third-party logistics provider with ISO 9001:2015 A total of 7 acquisitions came from private equity firms. medication, optimizing supply chain efficiency and enhancing patient care. AmerisourceBergen World Courier opens new distribution center in Australia In March 2016 Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.[10]. Federal prosecutors say the drug wholesaler AmerisourceBergen Corp. failed to report suspicious orders for . stockholders, and we look forward to continuing our success as part of Pennsylvania Distribution with Acquisitions, Pennsylvania Distribution with Divestitures, Recently Acquired United States Companies, M&A research that takes seconds (not all afternoon), Better understand your customers and prospects. customary closing conditions. expectations. Please be assured this name change and any impacts will happen over time, in carefully planned, controlled phases and communicated well in advance. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. the March quarter of 2015. Healthcare Conference in San Francisco on January 13, 2015. pharmaceuticals, biosimilars and innovative therapies such as cell and gene MWI will be presenting at the J.P. Morgan Healthcare Conference in San to have them join AmerisourceBergen, said Steven H. Collis, AmerisourceBergen MWI operates and in AmerisourceBergen's future operating results relating to The acquisition of MWI is expected to contribute approximately 8 cents will be accessible on the Investors pages of our website at The merger agreement, including the parties ability to satisfy the conditions to These supplemental measures may vary from, and may not be comparable to, similarly titled measures by other companies. From outside the U.S., dial +1 (412)-317-0088. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. Join Mergr and gain access to AmerisourceBergens M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the distribution sector. The Board of Directors of MWI has Includes $5M of intersegment eliminations. AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel. AmerisourceBergen management believes that this non-GAAP financial measure is useful to investors because it eliminates the impact of items that are unusual, unpredictable, and non-recurring in nature. there is a heightened demand for rigorous and customized storage solutions. Read their testimonials. Therefore, the Company believes that the presentation of this non-GAAP financial measure provides useful supplementary information to, and facilitates additional analysis by, investors. Building An Integrated Biopharma Commercialization Services Offering About AmerisourceBergen The parties expect the transaction to close during AmerisourceBergen Corporation (NYSE: ABC) and TPG Inc. (NASDAQ: TPG) will acquire cancer services firm OneOncology from global growth equity company General Atlantic for $2.1 billion. The company has provided the non-GAAP financial measures in the press release, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. AmerisourceBergen is one of the largest global pharmaceutical sourcing and Through our daily workand powered by our 22,000 associateswe are united in our responsibility to create healthier futures. Health Economics, Market Access & Regulatory Consulting, Patient Access, Affordability & Adherence Services, Global Storage, Transport & Outsourced Logistics. Enter the username and email address associated with your account. AmerisourceBergens financial and strategic position enable this next evolution of enhancing our ability to provide healthcare capabilities across regions and deliver innovative solutions for our upstream and downstream partners. We sell more than 50,000 Tackling performance requirements in the more prescriptive world of IVDR, How tighter rules modernize and safeguard Indias medical devices market, PharmaLexexpands Australia footprint through merger plan with pharmacovigilance leader Cpharm, IPI speaks with experts at PharmaLex on Integrated Product Development, Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners. The tender offer is conditioned on MWIs stockholders This certification allows 1. Adjusted diluted EPS is presented because management uses this non-GAAP financial measure to evaluate the Companys operating performance, to perform financial planning, and to determine incentive compensation. AmerisourceBergen has acquired in 10 different US states, and 2 countries. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. AmerisourceBergen, TPG to acquire specialty practice network OneOncology in $2.1B deal. Conshohocken, Pa AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of its acquisition of the majority of Walgreens Boots Alliances Alliance Healthcare businesses for $6.275 billion in cash, subject to a customary working capital and net debt adjustment, and 2 million shares of AmerisourceBergen common stock. We align supply chain strategy to your business . commence a tender offer no later than January 26, 2015, to acquire all tender offer with the SEC. ABC Order TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network Among the factors that could cause actual results to differ materially from those projected, anticipated, or implied are the following: unfavorable trends in brand and generic pharmaceutical pricing, including in rate or frequency of price inflation or deflation; competition and industry consolidation of both customers and suppliers resulting in increasing pressure to reduce prices for our products and services; changes in the United States healthcare and regulatory environment, including changes that could impact prescription drug reimbursement under Medicare and Medicaid; increasing governmental regulations regarding the pharmaceutical supply channel; declining reimbursement rates for pharmaceuticals; continued federal and state government enforcement initiatives to detect and prevent suspicious orders of controlled substances and the diversion of controlled substances; continued prosecution or suit by federal, state and other governmental entities of alleged violations of laws and regulations regarding controlled substances, including due to failure to achieve a global resolution of the multi-district opioid litigation and other related state court litigation, and any related disputes, including shareholder derivative lawsuits; increased federal scrutiny and litigation, including qui tam litigation, for alleged violations of laws and regulations governing the marketing, sale, purchase and/or dispensing of pharmaceutical products or services, and associated reserves and costs; failure to comply with the Corporate Integrity Agreement; material adverse resolution of pending legal proceedings; the retention of key customer or supplier relationships under less favorable economics or the adverse resolution of any contract or other dispute with customers or suppliers; changes to customer or supplier payment terms, including as a result of the COVID-19 impact on such payment terms; the integration of the Alliance Healthcare businesses into the Company being more difficult, time consuming or costly than expected; the Companys or Alliance Healthcares failure to achieve expected or targeted future financial and operating performance and results; the effects of disruption from the acquisition and related strategic transactions on the respective businesses of the Company and Alliance Healthcare and the fact that the acquisition and related strategic transactions may make it more difficult to establish or maintain relationships with employees, suppliers and other business partners; the acquisition of businesses, including the Alliance Healthcare businesses and related strategic transactions, that do not perform as expected, or that are difficult to integrate or control, or the inability to capture all of the anticipated synergies related thereto or to capture the anticipated synergies within the expected time period; risks associated with the strategic, long-term relationship between Walgreens Boots Alliance, Inc. and the Company, including with respect to the pharmaceutical distribution agreement and/or the global generic purchasing services arrangement; managing foreign expansion, including non-compliance with the U.S. Foreign Corrupt Practices Act, anti-bribery laws, economic sanctions and import laws and regulations; financial market volatility and disruption; changes in tax laws or legislative initiatives that could adversely affect the Company's tax positions and/or the Company's tax liabilities or adverse resolution of challenges to the Company's tax positions; substantial defaults in payment, material reduction in purchases by or the loss, bankruptcy or insolvency of a major customer, including as a result of COVID-19; the loss, bankruptcy or insolvency of a major supplier, including as a result of COVID-19; financial and other impacts of COVID-19 on our operations or business continuity; changes to the customer or supplier mix; malfunction, failure or breach of sophisticated information systems to operate as designed; risks generally associated with data privacy regulation and the international transfer of personal data; natural disasters or other unexpected events, such as additional pandemics, that affect the Companys operations; the impairment of goodwill or other intangible assets (including any additional impairments with respect to foreign operations), resulting in a charge to earnings; the Company's ability to manage and complete divestitures; the disruption of the Company's cash flow and ability to return value to its stockholders in accordance with its past practices; interest rate and foreign currency exchange rate fluctuations; declining economic conditions in the United States and abroad; and other economic, business, competitive, legal, tax, regulatory and/or operational factors affecting the Company's business generally.